Healthcare - Biotechnology - NASDAQ - US
$ 0.3397
-2.92 %
$ 5.87 M
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-19.4 M
OPERATING INCOME
-18.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
TransCode Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 517 K |
| Gross Profit | -517 K |
| Operating Expenses | 19.4 M |
| Operating Income | -19.4 M |
| Other Expenses | -872 K |
| Net Income | -18.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.5 | 98.6 K | 42.5 K | 0 | 0 | 0 |
| Gross Profit | (0.5) | 98.6 K | 42.5 K | 0 | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 19.4 | 17.6 | 5.9 | 0.7 | 0.5 | 0.4 |
| Selling, General and Administrative Expenses | 6.6 | 8.4 | 3.4 | 0.4 | 0.2 | 0.3 |
| Research and Development Expenses | 12.3 | 10.2 | 2.8 | 0.3 | 0.2 | 82.5 K |
| Operating Income | (19.4) | (18.7) | (6.2) | (0.7) | (0.5) | (0.4) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | (55.9) | 17.6 | 95.1 K | 0.4 | 0.2 | 0 |
| Total Other Income | 0.9 | 1.1 | (0.7) | (1.6) | (0.2) | 69.4 K |
| Pre-Tax Income | (18.5) | (17.6) | (6.8) | (2.3) | (0.6) | (0.5) |
| NET INCOME | ||||||
| Tax Provision | 0 | 17.6 | 95.1 K | 0.4 | 0.2 | 69.4 K |
| Net Income | (18.5) | (35.1) | (6.9) | (2.7) | (0.8) | (0.5) |
| EPS | 104 | 2.2 K | 659 | 343 | 119 | 70.8 |